Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

The silent treatment – researching gene silencing for Alzheimer’s, Parkinson’s and motor neurone disease

The science behind gene-silencing technology and the barriers and challenges faced by drug developers

- PMLiVE

What does HEOR really mean in 2025?

Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of people aged 60+ years is expected to soar. This both signals remarkable progress...

Petauri Evidence

- PMLiVE

Meet the Petauri experts at World EPA Congress

We are delighted to announce that market access and HEOR experts from Mtech Access - Powered by Petauri will be attending World Evidence, Pricing and Access Congress in Amsterdam on...

Petauri Evidence

Biogen Idec building

Biogen/Eisai’s Alzheimer’s drug approved by FDA for monthly maintenance dosing

The neurodegenerative disease affects almost seven million people in the US

- PMLiVE

Pfizer shares positive late-stage results for Braftovi regimen in colorectal cancer

The combination was approved in the US last month to treat BRAF V600E-mutant disease

- PMLiVE

Havas Health Network launches Havas Life London

The agency will offer brand, corporate and cause-related communications in global health and rare diseases

- PMLiVE

Promiscuous strategists

Good strategists are good for other things too

- PMLiVE

How to make your Medical Education sync with your marketing by EatMoreFruit’s Bethany Lowes Bush

Medical education faces challenges. Time is scarce. Resources are tight. Information overload is real. But by delivering genuine value through innovative formats that respect how HCPs actually learn and consume...

EatMoreFruit

- PMLiVE

AbbVie and Neomorph enter molecular glue degrader partnership worth $1.64bn

The companies are aiming to develop MGDs for targets across oncology and immunology

- PMLiVE

AstraZeneca/Daiichi Sankyo survey reveals breast cancer misconceptions in Europe

The questionnaire gathered insights from 7,750 adults across five countries

- PMLiVE

UK drug repurposing study identifies several potential dementia treatments

An estimated 982,000 people in the UK are currently living with the neurodegenerative disease

- PMLiVE

Creating and sustaining university biotech spin-outs

Part 1: Driving the future economy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links